These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Management of ovarian cancer in the renal transplant recipient with cyclophosphamide used as an immunosuppressive and antineoplastic agent. Vincent F; Michel M; Marrast AC; Bensousan TA; Glotz D; Duboust A Transplant Proc; 1995 Aug; 27(4):2432. PubMed ID: 7652865 [No Abstract] [Full Text] [Related]
5. Gynecologic aspects of malignancies following immunosuppressive or cytotoxic therapy. Deppe G Prog Clin Biol Res; 1981; 70():375-8. PubMed ID: 7031697 [No Abstract] [Full Text] [Related]
7. Adult cytomegalic inclusion retinitis. Wyhinny GJ; Apple DJ; Guastella FR; Vygantas CM Am J Ophthalmol; 1973 Nov; 76(5):773-81. PubMed ID: 4355949 [No Abstract] [Full Text] [Related]
8. Effects of cytomegalovirus infection on renal function in kidney transplant recipients. Choi SJ; Kim NH; Cho CK; Chung SY; Kim HJ; Choi KC; Kim SK Transplant Proc; 1996 Jun; 28(3):1523-4. PubMed ID: 8658769 [No Abstract] [Full Text] [Related]
9. Correlation of virology and clinical course of cytomegalovirus retinitis. Aaberg TM; Cesarz TJ; Rytel MW Am J Ophthalmol; 1972 Sep; 74(3):407-15. PubMed ID: 4340896 [No Abstract] [Full Text] [Related]
10. Retinitis: a manifestation of primary or secondary cytomegalovirus infection? Murray HW Arch Intern Med; 1978 Jan; 138(1):163. PubMed ID: 202209 [No Abstract] [Full Text] [Related]
11. Simultaneous aspergillus endophthalmitis and cytomegalovirus retinitis after kidney transplantation. Weiss JN; Hutchins RK; Balogh K Retina; 1988; 8(3):193-8. PubMed ID: 2852837 [TBL] [Abstract][Full Text] [Related]
12. The emergence of cytomegalovirus resistance to ganciclovir therapy in kidney transplant recipients. Nogueira E; Ozaki KS; Tomiyama H; Granato CF; Camara NO; Pacheco-Silva A Int Immunopharmacol; 2006 Dec; 6(13-14):2031-7. PubMed ID: 17161359 [TBL] [Abstract][Full Text] [Related]